HealthLeaders Media September 3, 2024
Eric Wicklund

Advocates are once again lobbying the White House and Congress to extend a waiver on using telemedicine to prescribe controlled medications, while the DEA prepares a new rule that could cause even more discord.

KEY TAKEAWAYS

– A pandemic-era waiver that enables providers to use telemedicine to prescribe controlled medications is set to expire at the end of the year.

– The DEA is awaiting federal review of new rules for telemedicine prescriptions, though some say the proposal will further restrict the use of virtual care.

– Telehealth advocates are asking for the waiver to be extended another two years so that the DEA has time to create rules that would appeal to everyone.

Telehealth advocates are gearing up for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Telehealth gets short extension, physician pay is cut in spending bill
Amazon One Medical: the beginning of a text-based TeleHealth revolution?
Congress Extends Hospice Telehealth Flexibilities
Telehealth Pathway for IBD Surgery Expanded Access to Care in Small Study
Senior Living Operators, Experts Urge Extension of Medicare Telehealth, Post-Acute Waivers

Share This Article